support the site ⋅ become a member ⋅ unscramble the egg
(tag_directory)
free120  nbme24  nbme23  nbme22  nbme21  nbme20  nbme19  nbme18  nbme17  nbme16  nbme15  nbme13 

NBME 24 Answers

nbme24/Block 4/Question#36 (19.2 difficulty score)
A 68-year-old woman comes to the emergency ...
Alendronate🔍
tags:

Login to comment/vote.


 +9  upvote downvote
submitted by mousie(160),
unscramble the site ⋅ become a member ($36/month)

rtasen""do ear ah,ssnopshBteipo nommlyoc edsu to reet/tneprtva oeos.spirtoos stMo conomm saederv ecftfse ear hsiotiEgpas etp(ansit doulhs eakt ihtw retwa dan eb iprghtu rfo at steal u,0en3si)tm sensrosicotOe of teh ajw, and pcataliy rfaoelm trssse uacfe.rtrs e-tnak igrht fmor AF 1082 pg 174

almondbreeze  FA 2019 pg 248 pill-induced esophagitis : bisphosphonates, ferrous sulfate, NSAIDs, potassium chloroide, tetracyclines +2  



pharm causes of pill-induced esophagitis = bisphosphonates, tetracyclines, NSAIDs, iron, potassium chloride

bisphosphonates MOA = bind hydroxapatite to reduce osteoclast activity (used in osteoporosis, Paget disease of bone, osteogenesis imperfecta, hypercalcemia and mets to bone)

osteoporosis pharm

  1. Ca2+/Vit D supplementation (prophylaxis)

  2. bisphosphonates - ADMEs = esophagitis, ONJ, atypical femoral stress fractures

  3. pulsatile PTH analogs (teriparatide) = only one that incr bone growth (stimulates osteoblasts) --> transient hypercalcemia, also incr risk of osteosarcoma (dont give to paget dz of bone or any cancer pt)

  4. SERM (raloxifene = antagonist at breasts and uterus, AGONIST at bone = no incr risk of endometrial hyperplasia...but still incr risk of thromboembolism)

  5. denosumab (mab against RANKL i.e. mimics OPG)

  6. rarely calcitonin

sunshinesweetheart  IGNORE ALLLLL MY OTHER POSTS lol I just learned text boxes. brb will continue helping no one/jumping out a window +1  



pharm causes of pill-induced esophagitis = bisphosphonates, tetracyclines, NSAIDs, iron, potassium chloride

bisphosphonates MOA = bind hydroxapatite to reduce osteoclast activity (used in osteoporosis, Paget disease of bone, osteogenesis imperfecta, hypercalcemia and mets to bone)

osteoporosis pharm - Ca2+/Vit D supplementation (prophylaxis) - bisphosphonates - pulsatile PTH analogs (teriparatide) = only one that incr bone growth (stimulates osteoblasts) --> transient hypercalcemia, also incr risk of osteosarcoma (dont give to paget dz of bone or any cancer pt) - SERM (raloxifene = antagonist at breasts and uterus, AGONIST at bone = no incr risk of endometrial hyperplasia...but still incr risk of thromboembolism) - denosumab (mab against RANKL i.e. mimics OPG) - rarely calcitonin




pharm causes of pill-induced esophagitis = bisphosphonates, tetracyclines, NSAIDs, iron, potassium chloride

bisphosphonates MOA = bind hydroxapatite to reduce osteoclast activity (used in osteoporosis, Paget disease of bone, osteogenesis imperfecta, hypercalcemia and mets to bone)

osteoporosis pharm

  1. Ca2+/Vit D supplementation (prophylaxis)

  2. bisphosphonates - pulsatile PTH analogs (teriparatide) = only one that incr bone growth (stimulates osteoblasts) --> transient hypercalcemia, also incr risk of osteosarcoma (dont give to paget dz of bone or any cancer pt)

  3. SERM (raloxifene = antagonist at breasts and uterus, AGONIST at bone = no incr risk of endometrial hyperplasia...but still incr risk of thromboembolism)
  4. denosumab (mab against RANKL i.e. mimics OPG) - rarely calcitonin
sunshinesweetheart  GOT IT IN LIST FORM #procrastinating +  



pharm causes of pill-induced esophagitis = bisphosphonates, tetracyclines, NSAIDs, iron, potassium chloride

bisphosphonates MOA = bind hydroxapatite to reduce osteoclast activity (used in osteoporosis, Paget disease of bone, osteogenesis imperfecta, hypercalcemia and mets to bone)

osteoporosis pharm 1. Ca2+/Vit D supplementation (prophylaxis) 2. bisphosphonates - pulsatile PTH analogs (teriparatide) = only one that incr bone growth (stimulates osteoblasts) --> transient hypercalcemia, also incr risk of osteosarcoma (dont give to paget dz of bone or any cancer pt) 3. SERM (raloxifene = antagonist at breasts and uterus, AGONIST at bone = no incr risk of endometrial hyperplasia...but still incr risk of thromboembolism) 4. denosumab (mab against RANKL i.e. mimics OPG) - rarely calcitonin

sunshinesweetheart  ha I am bad at using websites and can't make this a list that doesn't transform into a paragraph :( sorry +